Brianna LaPaglia slams GLP-1 drug usage. 'You're all gonna die.'

Brianna "Chickenfry" LaPaglia, in a March 10 TikTok video, got candid about the growing use of GLP-1 weight loss medication.
Hoodline

Galveston Lab Tests Weight-Loss Shot As Anti-Aging Weapon

Tirzepatide, which is marketed as Zepbound for chronic weight management, is a dual GIP and GLP-1 receptor agonist that has ...
24/7 Wall St.

Is Hims & Hers Really the Growth Stock to Buy That It Appears?

Hims & Hers Health (NYSE:HIMS) looked like a fallen growth star earlier this year. The telehealth platform was hammered by the FDA’s aggressive crackdown on compounded GLP-1 drugs, complete with ...

In 2036, Investors Will Regret Not Loading Up on This Multibagger in the Making

A multibagger stock is one that has doubled your money or more. Peter Lynch, the highly respected investment manager who ran the Magellan Fund for 14 years, coined the term in his book, One Up on Wall ...